Low Rates of Hepatitis A and B Vaccination in Patients with Chronic Hepatitis C at an Urban Methadone Maintenance Program
| Autor: | Dawn A. Fishbein, Alain H. Litwin, Uriel R. Felsen |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
Hepatitis B virus Methadone maintenance viruses Medicine (miscellaneous) Article Liver disease Opiate Substitution Treatment medicine Humans Hepatitis B Vaccines Hepatitis Hepatitis A Vaccines business.industry fungi virus diseases Hepatitis A General Medicine Hepatitis C Chronic Middle Aged Patient Acceptance of Health Care biochemical phenomena metabolism and nutrition Hepatitis B Opioid-Related Disorders medicine.disease Virology digestive system diseases Vaccination Psychiatry and Mental health Clinical Psychology Female Hepatitis A virus Substance Abuse Treatment Centers Viral disease business Methadone medicine.drug |
| Zdroj: | Journal of Addictive Diseases. 29:461-465 |
| ISSN: | 1545-0848 1055-0887 |
| DOI: | 10.1080/10550887.2010.509281 |
| Popis: | Patients with chronic hepatitis C virus (HCV) are at increased risk for complications of liver disease if they become infected with the hepatitis A (HAV) or hepatitis B (HBV) viruses. The authors examined the rates of testing for HAV, HBV, and HCV, as well as rates of vaccination against HAV and HBV in patients with chronic HCV in a random sample (N = 207) of medical records of patients enrolled in a methadone maintenance program. Almost all patients reviewed were tested for HAV, HBV, and HCV. Of the 111 patients with chronic HCV, 53 (48.6%) and 68 (63%) lacked immunity to HAV and HBV, respectively. Of those lacking immunity, 29 (54.7%) and 2 (2.9%) were vaccinated for HAV and HBV, respectively. Despite high rates of testing for HAV, HBV, and HCV at a methadone maintenance program, approximately half of those with chronic HCV eligible for the HAV vaccine received it, and few of those eligible for HBV vaccine received it. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|